ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 170 filers reported holding ABCELLERA BIOLOGICS INC in Q2 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $40,679 | -21.4% | 13,743 | +20.3% | 0.00% | – |
| Q1 2024 | $51,769 | -92.8% | 11,428 | -88.0% | 0.00% | – |
| Q1 2023 | $717,868 | -9.4% | 95,208 | +21.8% | 0.00% | – |
| Q4 2022 | $792,075 | -2.5% | 78,191 | -4.7% | 0.00% | – |
| Q3 2022 | $812,000 | -1.5% | 82,054 | +6.1% | 0.00% | – |
| Q2 2022 | $824,000 | +46.4% | 77,359 | +175.2% | 0.00% | – |
| Q3 2021 | $563,000 | +79.3% | 28,110 | +97.2% | 0.00% | – |
| Q2 2021 | $314,000 | – | 14,256 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $28,452,416 | 91.13% |
| Founders Fund Growth Management, LLC | 407,017 | $3,068,908 | 14.23% |
| Gruss & Co., LLC | 167,500 | $1,262,950 | 7.99% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $30,952,416 | 3.25% |
| Belmont Capital, LLC | 510,000 | $3,845,400 | 3.18% |
| Prosight Management, LP | 753,528 | $5,681,601 | 2.69% |
| Intellectus Partners, LLC | 872,483 | $6,578,520 | 2.08% |
| Casdin Capital, LLC | 2,520,000 | $19,000,800 | 1.56% |
| GUARDIAN CAPITAL ADVISORS LP | 1,786,414 | $13,022,958 | 1.50% |
| Orbimed Advisors | 4,180,768 | $31,522,991 | 0.62% |